Venture capital firm based in Cambridge, UK
Trent AI secures £9.8m to build continuous security for autonomous AI agents. Read more
BeyondMath secures seed funding to run simulations in seconds with generative physics. Read more
£8.9m extension enables end-to-end antibody expression and validation on benchtop microfluidics. Read more
Series A rises to £69.3m as T-Therapeutics advances TCR bispecifics to clinic. Read more
Cambridge GaN Devices secures $32M funding to drive energy-efficient innovations, set to impact electric vehicles and data centres. Read more
Forefront RF just snagged £16 million in funding to propel its revolutionary semiconductor technology, setting the stage to transform the next generation of multi-band smartphones and smartwatches. Read more
Epitopea secures a £500K grant to revolutionize cancer treatment with cutting-edge immunotherapies targeting hidden antigens—ushering in a new era in the fight against cancer. Read more
| Biotech | 50.0% |
| Hardware | 21.4% |
| Cyber security | 7.1% |
| Medical Technology | 7.1% |
| AI | 7.1% |
| Healthtech | 7.1% |